Compare ARCB & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARCB | TMDX |
|---|---|---|
| Founded | 1923 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 1994 | 2019 |
| Metric | ARCB | TMDX |
|---|---|---|
| Price | $134.97 | $85.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | $122.75 | ★ $148.22 |
| AVG Volume (30 Days) | 222.6K | ★ 580.0K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.38% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.61 |
| Revenue | ★ $1,657,864,000.00 | $605,494,000.00 |
| Revenue This Year | $7.00 | $24.25 |
| Revenue Next Year | $5.80 | $18.75 |
| P/E Ratio | ★ N/A | $141.87 |
| Revenue Growth | 12.56 | ★ 37.13 |
| 52 Week Low | $59.43 | $60.11 |
| 52 Week High | $176.69 | $156.00 |
| Indicator | ARCB | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 45.15 | 47.17 |
| Support Level | $133.90 | $81.34 |
| Resistance Level | $142.67 | $95.18 |
| Average True Range (ATR) | 5.56 | 3.86 |
| MACD | 0.26 | -1.01 |
| Stochastic Oscillator | 38.48 | 23.27 |
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.